MediShield Life

MediShield Life is Singapore's basic health insurance scheme, protecting all Singapore Citizens and permanent residents against large medical bills for life, regardless of age or pre-existing conditions (MOH, accessed Oct 2026). Every citizen and permanent resident is covered automatically (CPF Board, accessed Oct 2026). MOH administers the scheme policy under the MediShield Life Scheme Act, CPF Board handles premiums and member records, and the MediShield Life Council advises the Minister for Health on benefits, premiums and the MediShield Life Fund. MediShield Life is the insurance layer of the "3Ms" in healthcare financing, between personal medisave savings and the medifund safety net.

Coverage and design

MediShield Life pays part of the bill for hospitalisation and day surgery, selected outpatient treatments such as kidney dialysis, cancer drug treatment and radiotherapy, and care in community hospitals and inpatient palliative care (CPF Board, accessed Oct 2026). The remainder can be paid with MediSave, up to withdrawal limits, or cash. MOH states that MediShield Life benefits are sized for subsidised treatment in public-hospital wards, so stays in Class A or B1 wards or in private hospitals leave a smaller share of the bill covered (MOH, accessed Oct 2026). That calibration is why many residents buy an Integrated Shield Plan, which wraps private cover around MediShield Life.

MediShield Life launched in 2015, succeeding the earlier MediShield scheme; a Review Committee appointed in November 2013 designed it, and the Government accepted that committee's recommendations on 27 June 2014 (MOH reviews, accessed Oct 2026). Its defining reform was universality: cover cannot be refused for pre-existing conditions and continues at any age. MOH lists standard exclusions, including cosmetic surgery, most dental work, vaccinations, normal maternity charges, overseas treatment, private nursing, and charges incurred more than seven calendar days after a patient is certified fit for discharge with a feasible discharge option (MOH benefits, accessed Oct 2026). Singaporeans permanently located overseas can apply to suspend premium payment.

Claim limits, deductibles and co-insurance

MediShield Life pays the part of a bill within its claim limits, minus a deductible and co-insurance (CPF Board, accessed Oct 2026). For admissions on or after 1 June 2026, MOH's limits include S$830 per day for a normal ward plus an extra S$800 per day for the first two days of an inpatient stay; S$5,140 per day in intensive care; S$370 per day in a rehabilitative community-hospital stay and S$570 for sub-acute care; S$230 per day for psychiatric care up to 60 days a policy year; and surgical limits from S$240 to S$3,900 by procedure table and class (MOH benefits, accessed Oct 2026). Outpatient limits include S$1,750 a month for kidney dialysis and S$200 to S$12,800 a month for cancer drugs depending on the drug. The policy-year limit is S$200,000, and there is no lifetime limit.

The deductible is payable once per policy year, and co-insurance ranges from 10% down to 3%, falling as the claimable amount rises (CPF Board, accessed Oct 2026). Under the 2024 Review, the inpatient deductible rises by up to S$1,500 in two phases, on 1 April 2025 and 1 April 2027, and a new S$500 yearly outpatient deductible applies from 1 June 2026 (MOH, 15 Oct 2024). The fetched MOH pages do not state the full deductible schedule by age and ward class in text, so exact deductibles should be checked on CPF Board's personal healthcare dashboard or claims calculator.

Premiums and subsidies

MediShield Life premiums are age-banded and can be paid in full from the member's or a family member's MediSave (CPF Board, accessed Oct 2026). For policies starting or renewing on or after 1 April 2025, annual premiums before subsidies, including 9% GST, range from S$200 for ages 1–20 (age next birthday) through S$503 for 31–40, S$903 for 51–60 and S$1,326 for 66–70, to S$2,826 above age 90 (MOH premium tables, accessed Oct 2026).

Means-tested premium subsidies apply to Singapore Citizens with household monthly income per person up to S$3,600 living in a home with an Annual Value (AV) of S$31,000 or less. The subsidy rises with age and falls with income: from 25%, 20% and 15% for ages 1–40 in the lower, lower-middle and upper-middle income tiers, up to 60%, 55% and 40% above age 90. Permanent residents receive half the citizen rates; rates are 10 percentage points lower for homes with an AV of S$21,001–S$31,000; and owners of more than one property get none (MOH premium tables, accessed Oct 2026). Pioneer Generation members receive 40% to 60% premium subsidies from age 66, and Merdeka Generation members an additional 5% (ages 60–75) or 10% (76 and above). People who still cannot pay after subsidies and family help can seek Additional Premium Support; MOH states that no one will be denied coverage because they cannot pay premiums (MOH reviews, accessed Oct 2026).

Reviews and the premium-versus-benefit trade-off

MediShield Life is reviewed periodically by the MediShield Life Council: the Government accepted review recommendations in December 2020, accepted outpatient cancer-drug changes in August 2021 (effective September 2022), and accepted the 2024 Review on 15 October 2024 (MOH reviews, accessed Oct 2026). The 2024 Review raised the first-two-day ward limit from S$1,000 to S$1,630 a day, the ICU limit from S$2,200 to S$5,140 a day, the policy-year limit from S$150,000 to S$200,000 and the dialysis limit from S$1,100 to S$1,750 a month (MOH, 15 Oct 2024).

Those benefits cost money. MOH said premiums would rise by S$1.8 billion over the three-year cycle, capped at 35% and phased from April 2025 to March 2028, an average 22% per policyholder by year three. The Government committed S$4.1 billion — S$3.4 billion in MediSave top-ups and S$0.7 billion in premium subsidies — which it said more than offsets the increases for over nine in ten Singaporeans, and raised the maximum premium subsidy from 50% to 60% from 1 April 2025. The trade-off is explicit: higher deductibles shift small bills back to patients to restrain premiums, while larger limits pool the risk of catastrophic bills. Critics of co-payment argue that deductibles can deter lower-income patients; the official answer is that subsidies, MediSave and medifund absorb what patients cannot.